Konventionelle nuklearmedizinische Bildgebung bei Hyperparathyreoidismus

Beim primären Hyperparathyreoidismus liegt in der Regel ursächlich ein solitäres Nebenschilddrüsenadenom vor. Die präoperative Lokalisationsdiagnostik ist hilfreich bei der Auswahl des geeigneten Operationsverfahrens. Für die konventionelle nuklearmedizinische Diagnostik einer Nebenschilddrüsenüberfunktion wird neben der Sonografie der Halsweichteile standardmäßig die Bildgebung mit ^99 mTc-Sestamibi (MIBI) eingesetzt.

Publikationsverlauf

Artikel online veröffentlicht:
10. März 2021

• Literatur

• 1 Sheu-Grabellus S-Y, Schmid KW. Pathologie der Nebenschilddrüse. Pathologe 2015; 36: 229-236
• 2 Noda S, Onoda N, Kashiwagi S. et al. Strategy of operative treatment of hyperparathyroidism using US scan and (99 m) Tc-MIBI SPECT/CT. Endocr J 2014; 61: 225-230
• 3 Huppert BJ. Reading CC. Parathyroid sonography: imaging and intervention. – PubMed – NCBI. Im Internet (Stand: 23.07.2020): https://www.ncbi.nlm.nih.gov/pubmed/?term=Huppert+Parathyroid+sonography%3A+imaging+and+intervention
• 4 Schlosser K, Wirowski D. Primärer Hyperparathyreoidismus – Teil 1: Epidemiologie, Anatomie und Symptomatik. Allg Viszeralchir Up2date 2013; 1: 23-26
• 5 Kedarisetty S, Fundakowski C, Ramakrishnan K. et al. Clinical value of Tc99 m-MIBI SPECT/CT versus 4 D-CT or US in management of patients with hyperparathyroidism. Ear Nose Throat J 2019; 98: 149-157
• 6 Guilmette J, Sadow PM. Parathyroid pathology. Surg Pathol Clin 2019; 12: 1007-1019
• 7 Schlosser K, Wirowski D. Primärer Hyperparathyreoidismus – Teil 2: Diagnostisches und therapeutisches Vorgehen. Allg Viszeralchir Up2date 2013; 1: 39-56
• 8 Zeng M, Liu W, Zha X. et al. 99 mTc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism. Ren Fail 2019; 41: 885-892
• 9 Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005; 35: 266-276
• 10 Cheung K, Wang TS, Farrokhyar F. et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 2012; 19: 577-583
• 11 Rager O, Radojewski P, Dumont RA. et al. Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules. Gland Surg 2019; 8: S118-S125
• 12 Arbab AS, Koizumi K, Toyama K. et al. Uptake of technetium-99 m-tetrofosmin, technetium-99 m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556
• 13 Schmidt M, Schenke S. Update 2019 zur MIBI-Szintigrafie bei hypofunktionellen Schilddrüsenknoten. Nuklearmediziner 2019; 42: 174-182
• 14 Treglia G, Sadeghi R, Schalin-Jäntti C. et al. Detection rate of (99 m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck 2016; 38 : (Suppl. 01): E2159-2172
• 15 Taillefer R, Boucher Y, Potvin C. et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99 m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807
• 16 Xue J, Liu Y. , ji T. Comparison between technetium-99 m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. Nucl Med Commun 2018; 39: 1129-1137
• 17 Sharma J, Mazzaglia P, Milas M. et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99 m sestamibi modality? Surgery. 2006; 140: 856-863 ; discussion 863-865
• 18 Coakley AJ, Kettle AG, Wells CP. et al. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794
• 19 Bekanntmachung der aktualisierten diagnostischen Referenzwerte für nuklearmedizinische Untersuchungen. Bundesamt für Strahlenschutz; 2012: Im Internet (Stand: 23.07.2020): https://www.bfs.de/DE/themen/ion/anwendung-medizin/diagnostik/referenzwerte/referenzwerte_node.html
• 20 Hindié E, Ugur O, Fuster D. et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009; 36: 1201-1216
• 21 Wong KK, Fig LM, Gross MD. et al. Parathyroid adenoma localization with 99 mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 2015; 36: 363-375
• 22 Kushchayeva YS, Tella SH, Kushchayev SV. et al. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99 m sestamibi and 123I for localization of rapid washout parathyroid adenomas. Osteoporos Int 2019; 30: 1051-1057
• 23 Maccora D, Rizzo V, Fortini D. et al. Parathyroid scintigraphy in primary hyperparathyroidism: comparison between double-phase and subtraction techniques and possible affecting factors. J Endocrinol Invest 2019; 42: 889-895
• 24 Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism-an evidence-based analysis. Langenbecks Arch Surg 2009; 394: 765-784
• 25 Mshelia DS, Hatutale AN, Mokgoro NP. et al. Correlation between serum calcium levels and dual-phase (99 m)Tcsestamibi parathyroid scintigraphy in primary hyperparathyroidism. Clin Physiol Funct Imaging 2012; 32: 19-24
• 26 Silov G, Ozdal A, Erdoğan Z. et al. The relationship between technetium-99 m-methoxyisobutyl isonitrile parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism. Mol Imaging Radionucl Ther 2013; 22: 8-13
• 27 Jorna FH, Hollema H, Hendrikse HN. et al. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99 m)Tc-sestamibi imaging results. Exp Clin Endocrinol Diabetes 2009; 117: 406-412
• 28 Cordes M, Dworak O, Papadopoulos T. et al. MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers. Endocr Res 2018; 43: 141-148
• 29 Calva-Cerqueira D, Smith BJ, Hostetler ML. et al. Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 2007; 205: S38-44
• 30 Hassler S, Ben-Sellem D, Hubele F. et al. Dual-isotope 99 mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan. Clin Nucl Med 2014; 39: 32-36
• 31 Gayed IW, Kim EE, Broussard WF. et al. The value of 99 mTcsestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005; 46: 248-252
• 32 Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99 mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med 2008; 49: 2012-2017
• 33 Ozderya A, Temizkan S, Gul AE. et al. Biochemical and pathologic factors affecting technetium-99 m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism. Ann Nucl Med 2018; 32: 250-255
• 34 Aller SG, Yu J, Ward A. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009; 232: 1718-1722
• 35 Yamaguchi S, Yachiku S, Hashimoto H. Relation between technetium 99 m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. Wold J Surg 2002; : 29-34
• 36 Kao A, Shiau Y-C, Tsai S-C. et al. Technetium-99 m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistancerelated protein expression. Eur J Nucl Med Mol Imaging 2002; 29: 1012-1015
• 37 Sun SS, Shiau YC, Lin CC. et al. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99 m MIBI parathyroid image findings. Nucl Med Biol 2001; 28: 929-933
• 38 Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-372
• 39 Caldarella C, Treglia G, Pontecorvi A. et al. Diagnostic performance of planar scintigraphy using 99 mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med 2012; 26: 794-803
• 40 Nichols KJ, Tronco GG, Palestro CJ. Influence of multigland parathyroid disease on 99 mTc-Sestamibi SPECT/CT. Clin Nucl Med 2016; 41: 282-288
• 41 Takebayashi S, Hidai H, Chiba T. et al. Hyperfunctional parathyroid glands with 99 mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 1999; 40: 1792-1797
• 42 Erbil Y, Kapran Y, I?sever H. et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99 mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 2008; 195: 34-39
• 43 Elgazzar AH, Anim JT, Dannoon SF. et al. Ultrastructure of Hyperfunctioning Parathyroid Glands: Does it Explain Various Patterns of 99 mTc-sestamibi Uptake. World J Nucl Med 2017; 16: 145-149
• 44 Araz M, Çayir D, Erdoğan M. et al. Factors affecting the sensitivity of Tc-99 m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism. Nucl Med Commun 2017; 38: 117-123
• 45 Friedman K, Somervell H, Patel P. et al. Effect of calcium channel blockers on the sensitivity of preoperative 99 mTc-MIBI SPECT for hyperparathyroidism. Surgery 2004; 136: 1199-1204
• 46 Odparlik A, Hering AH. Lokalisationsdiagnostik von Nebenschilddrüsenadenomen mittels PET/CT. Der Nuklearmediziner 2020; 43: 244-248